<!DOCTYPE html>
<html>
<head>
	<title>Genomics England - Rare Diseases - Renal tubular acidosis</title>
	<meta charset="utf-8"/>
	<script type="text/javascript" src="inc/jquery.min.js"></script>
	<link rel="stylesheet" type="text/css" href="inc/style.css" />
	<!-- <script src="../file/js/modernizr.js"></script>  -->
</head>
<body>
	<div class="container">
		<h1>Renal tubular acidosis</h1>
		<div id="nav">
			<br /><br /><a href="index.html" style="margin-left:20px;">&#171; Back to homepage</a>
		</div>
		<div class="main">
			<ul class="tabs">
				<li>
					<input type="radio" checked name="tabs" id="tab1">
					<label for="tab1">Eligibility</label>
					<div id="tab-content1" class="tab-content animated fadeIn">
            
  <p class="preserve-new-lines">Relevant diseases:
- Distal renal tubular acidosis
- Renal Fanconi syndrome
- Gitelman and Bartter type 3 syndrome (Hypokalaemic alkalosis with hypomagnesaemia &amp; hypocalcalciuria)
- Bartter syndrome type 1, 2 &amp; 4 (Hypokalaemic alkalosis with hypercalciuria)
- Liddle syndrome (hypertensive hypokalaemic alkalosis)
- Gordon syndrome (hypertensive hyperkalaemic acidosis)
- Glucocorticoid remediable hypertension
- Apparent Mineralocorticoid excess
- Pseudohypoaldosteronism type1</p>

  <h3>Inclusion Criteria</h3>
  <p class="preserve-new-lines">- Renal acid-base or other electrolyte disorders of unknown aetiology.
AND
- Unaffected individuals have undergone appropriate screening for cryptic disease
- Individuals with severe or syndromic disease should be recruited according to standard guidance, preferably as trios
- In other cases, unaffected individuals should not be recruited. Recruitment in such families should favour multiplex families over single isolated cases. These singleton recruits will not contribute to the overall singleton monitoring metrics applied to GMCs.</p>

  <h3>Exclusion Criteria</h3>
  <p class="preserve-new-lines">- Prior genetic testing that identifies a pathogenic mutation in a gene known to cause one or more of the diseases detailed above.</p>

  <h3>Prior Genetic Testing</h3>
  <p class="preserve-new-lines">- Results should have been reviewed for all genetic tests undertaken, including disease-relevant genes in exome sequencing data. The patient is not eligible if they have a molecular diagnosis for their condition. 
- Genetic testing should continue according to routine local practice for this phenotype regardless of recruitment to the project; results of these tests must be submitted via the ‘Genetic investigations’ section of the data capture tool to allow comparison of WGS with current standard testing.  

PLEASE NOTE: The sensitivity of WGS compared to current diagnostic genetic testing has not yet been established. It is therefore important that tests which are clinically indicated under local standard practice continue to be carried out.</p>

  <h3>Genes</h3>
  <p class="preserve-new-lines">Testing of the following genes should be carried out PRIOR TO RECRUITMENT where this is in line with current local practice:
 - Distal renal tubular acidosis: SLC4A1, ATP6V0A4, ATP6V1B1
  - Hypokalaemic alkalosis with hypomagnesaemia &amp; hypocalciuria: SLC12A3, CLCNKB
  - Hypokalaemic alkalosis with hypercalciuria: SLC12A1, KCNJ1, BSND</p>

  <h3>Closing Statement</h3>
  <p class="preserve-new-lines">These requirements will be kept under continual review during the main programme and may be subject to change.</p>


					</div>
				</li>
				<li>
					<input type="radio" name="tabs" id="tab2">
					<label for="tab2">Phenotypes</label>
					<div id="tab-content2" class="tab-content animated fadeIn">
            
  <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0000124" onclick="window.open(this.href);return false;">Renal tubular dysfunction</a></h3>
    <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0001947" onclick="window.open(this.href);return false;">Renal tubular acidosis</a></h3>
    <p class="preserve-new-lines">Acidosis owing to malfunction of the kidney tubules with accumulation of metabolic acids and hyperchloremia, potentially leading to complications including hypokalemia, hypercalcinuria, nephrolithiasis and nephrocalcinosis.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0011038" onclick="window.open(this.href);return false;">Abnormality of renal resorption</a></h3>
    <p class="preserve-new-lines">An abnormality of renal absorption.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0011036" onclick="window.open(this.href);return false;">Abnormality of renal excretion</a></h3>
    <p class="preserve-new-lines">An altered ability of the kidneys to void urine and/or specific substances.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0000121" onclick="window.open(this.href);return false;">Nephrocalcinosis</a></h3>
    <p class="preserve-new-lines">Nephrocalcinosis is the deposition of calcium salts in renal parenchyma.

Comment:
Nephrocalcinosis can be intratubular or interstitial, and can be diagnosed by means of a radiologic exam (plain radiographs, ultrasonograms, or computed tomography scans) or via microscopic examination of the renal tissues. The term nephrocalcinosis most often applies to a generalized increase in renal calcium content.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0000787" onclick="window.open(this.href);return false;">Nephrolithiasis</a></h3>
    <p class="preserve-new-lines">The presence of calculi (stones) in the kidneys.

Comment:
Urinary stone disease is caused by supersaturation of the urine by stone forming substances including calcium, oxalate, and uric acid. Crystals or foreign bodies can act as a nidus for further stone formation. THe resulting kidney stones (calculi) lead to symptoms if they become impacted in the ureter.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0000822" onclick="window.open(this.href);return false;">Hypertension</a></h3>
    <p class="preserve-new-lines">The presence of chronic increased pressure in the systemic arterial system.

Comment:
Hypertension is sustained elevation of resting systolic BP (140 mm Hg or higher), diastolic BP (90 mm Hg or higher), or both.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0001949" onclick="window.open(this.href);return false;">Hypokalemic alkalosis</a></h3>
    <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0002917" onclick="window.open(this.href);return false;">Hypomagnesemia</a></h3>
    <p class="preserve-new-lines">An abnormally decreased magnesium concentration in the blood.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0003127" onclick="window.open(this.href);return false;">Hypocalciuria</a></h3>
    <p class="preserve-new-lines">An abnormally decreased calcium concentration in the urine (FMA:12274).</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0002150" onclick="window.open(this.href);return false;">Hypercalciuria</a></h3>
    <p class="preserve-new-lines"></p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0002153" onclick="window.open(this.href);return false;">Hyperkalemia</a></h3>
    <p class="preserve-new-lines">An abnormally increased potassium concentration in the blood.</p>
  
    <h3><a href="http://purl.obolibrary.org/obo/HP_0000847" onclick="window.open(this.href);return false;">Abnormality of renin-angiotensin system</a></h3>
    <p class="preserve-new-lines">An abnormality of the renin-angiotensin system.

Comment:
The renin-angiotensin system is a hormone system that regulates blood pressure and water (fluid) balance.</p>
  


					</div>
				</li>
				<li>
					<input type="radio" name="tabs" id="tab3">
					<label for="tab3">Clinical Tests</label>
					<div id="tab-content3" class="tab-content animated fadeIn">
            
  <p class="preserve-new-lines"></p>
  <ul>
    
    <li><strong>Glucose</strong><p class="preserve-new-lines"></p></li>
    
    <li><strong>Bone profile</strong><p class="preserve-new-lines">Please provide the following test results if they are available, in addition to the elements included in the generic laboratory test data model:</p></li>
    
    <li><strong>Extended renal biochemistry</strong><p class="preserve-new-lines"></p></li>
    
    <li><strong>Renal biochemistry</strong><p class="preserve-new-lines">Please provide the following test results if they are available, in addition to the elements included in the generic laboratory test data model:</p></li>
    
    <li><strong>Urine electrolytes</strong><p class="preserve-new-lines"></p></li>
    
    <li><strong>Urine dip - standard</strong><p class="preserve-new-lines"></p></li>
    
    <li><strong>General Imaging Diagnostics</strong><p class="preserve-new-lines">General imaging diagnostics report to capture reports that aren&#39;t included in the specific subclasses. Inherits all the elements in the abstract Imaging Diagnostics class and the abstract Investigation Class.</p></li>
    
    <li><strong>General Non-imaging Diagnostics</strong><p class="preserve-new-lines"></p></li>
    
    <li><strong>Metabolic biochemistry</strong><p class="preserve-new-lines"></p></li>
    
    <li><strong>Urine Protein</strong><p class="preserve-new-lines">Urine Protein result</p></li>
    
  </ul>


					</div>
				</li>
			</ul>
		</div>
	</div>
</body>
</html>
